Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115351Source: DataRank Database

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents is a research paper published in European Journal of Medicinal Chemistry (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.17)OA: greenTopics (28)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Shichun Lun,Yuxue Jiao ORCID,Wei Zhang ORCID,Ting Liu ORCID,Fan Yang ORCID

Live enrichment

PubMed:37116266 PMC:PMC10239758 OpenAlex:https://openalex.org/W4366607087

National Institute of Allergy and Infectious Diseases

Grant: AI155602

National Natural Science Foundation of China

Grant: 22107031

National Natural Science Foundation of China

Grant: 82073706

NIAID NIH HHS

Grant: R01 AI155602

National Institutes of Health

U.S. Department of Health and Human Services

FWCI

2.17

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10239758/pdf/nihms-1896588.pdf

BRONZEhttps://www.sciencedirect.com/science/article/am/pii/S0223523423003173

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10239758/pdf/nihms-1896588.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0223523423003173?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0223523423003173?httpAccept=text/plain

Fields of Study

Tuberculosis Research and EpidemiologyCancer therapeutics and mechanismsHIV/AIDS drug development and treatmentMedicineChemistryAntitubercular AgentsBacterial ProteinsMembrane ProteinsMembrane Transport ProteinsMicrobial Sensitivity TestsMycobacterium tuberculosisPyridines

MeSH Terms

Antitubercular AgentsBacterial ProteinsMembrane ProteinsMicrobial Sensitivity TestsMycobacterium tuberculosisPyridinesMembrane Transport Proteins

Keywords

ChemistryMethylamineStereochemistryPyridineBiochemistryStructure-Based Drug DesignMmpl3Mdr And Xdr TuberculosisPyridine-2-methylamine

Sustainable Development Goals

SDG 0: Good health and well-being

Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents

FAIR Checklist

Authors (9)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)